Valuation (52%) |
Company | Industry |
---|---|---|
P/E Ratio (TTM) | 0.69 | -7.93 |
PEG Ratio (TTM) | 0.02 | 1.63 |
P/S Ratio (TTM) | 1.81 | 2.52 |
P/B Ratio (TTM) | 0.18 | 1.64 |
P/FCF Ratio (TTM) | -16.62 | 10.98 |
Price to 5YR AVG Earnings Ratio | N/A | 5.14 |
Price to 5YR AVG FCF Ratio | N/A | 8.39 |
Profitability (75%) |
Company | Industry |
---|---|---|
ROA (TTM) | 24.97% | 7.01% |
ROE (TTM) | 34.11% | 11.19% |
Net Profit Margin (TTM) | 234.87% | 17.62% |
ROIC 5YR AVG | N/A | 12.16% |
Growth (25%) |
4QTR AVG | 3YR AVG | 5YR AVG |
---|---|---|---|
EPS | 45.84% | N/A | N/A |
Revenue | -12.38% | N/A | N/A |
Net Income | 48.29% | N/A | N/A |
Cash Flow | 52.88% | N/A | N/A |
Health (53%) |
Company | Industry |
---|---|---|
Current Ratio (TTM) | 34.24 | 1.74 |
Quick Ratio (TTM) | 34.21 | 1.56 |
D/E Ratio (TTM) | N/A | 0.66 |
Interest Coverage (TTM) | 46.42 | 12.30 |
Piotroski F-Score | 5 | 6 |
Altman Z-Score | 8.87 | 2.25 |
LTL to 5YR AVG FCF | N/A | 2.91 |
Shares Outstanding Growth 5YR AVG | N/A | 13.14% |